Clinical Trial Update: REVIVE (Response to the Ebola Virus Vaccine) [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 clinical trial (REVIVE) evaluating a response to an Ebola virus vaccine sponsored by Tulane University. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Snippet

Sponsor: Tulane University | Conditions: Ebola Virus Disease | Phase 4 | Status: RECRUITING